ABOUT ANTENGENE MANAGEMENT TEAM SCIENTIFIC ADVISORY BOARD BOARD OF DIRECTORS INVESTORS

SCIENTIFIC ADVISORY BOARD

Joe Camardo, M.D.

SENIOR VICE PRESIDENT OF CELGENE GLOBAL HEALTH AND GLOBAL MEDICAL AFFAIRS, CELGENE

Dr. Joseph S. Camardo, M.D., is a Member of the American College of Physicians Foundation and currently serves as Senior Vice President-Global Medical Affairs and Global Health at Celgene Corp. Dr. Camardo is also on the Board of Directors at ScripsAmerica, Inc., Mali Health Organizing Project and Rosemont College. Prior to Celgene, Dr. Camardo worked at several leading pharmaceuticals companies, including Forest Laboratories, Pfizer and Wyeth, where he held senior positions in medical affairs. He received his B.A., majoring in Biology from the University of Pennsylvania and a doctorate degree in Internal Medicine from Perelman School of Medicine, University of Pennsylvania.

Christian Jacques, M.D.

FORMER VICE PRESIDENT OF CLINICAL DEVELOPMENT AT CELGENE AND NOVARTIS

Dr. Christian Jacques, M.D., is co-founder and Chief Scientific Officer at Pharma Biotech Consultants, LLC. Previously, Dr. Jacques served as Vice President-Clinical Development at Celgene, during which he was in charge of multiple myeloma clinical developments at Celgene. Dr. Jacques also held multiple roles at Novartis, Johnson & Johnson and Sanofi prior to Celgene. Dr. Jacques is a hematologist oncologist by background and he trained for both his M.D. degree and his Internal Medicine degree at the Catholic University of Louvain, Belgium. Dr. Jacques has also been a hospital practitioner for 10 years.

Denis Miller, M.D.

GLOBAL HEAD OF ONCOLOGY, PAREXEL

Dr. Denis Miller, M.D. currently serves as Global Therapeutics Area Leader-Hematology and Oncology at Parexel. Prior to joining Parexel, Dr. Miller held multiple positions in pharmaceutical R&D and clinical oncology at Hoffmann-La Roche and Johnson & Johnson, as well as clinical research organizations. He has served in leadership roles at premier cancer centers, medical centers and hospitals including as Chairman, Department of Pediatrics at Memorial Sloan Kettering Cancer Center. Dr. Miller holds B.A. and M.D. degrees from Cornell University, and was a Fulbright Scholar at the University of London, Saint Mary's Hospital Medical School. He completed his post-graduate residency and fellowship training at the Children's Hospital Medical Center and Harvard Medical School, and is Board Certified in pediatrics and pediatric hematology/oncology.

James Phang, M.D.

HEAD, METABOLISM & CANCER SUSCEPTIBILITY SECTION OF NATIONAL CANCER INSTITUTE

Dr. James Phang, M.D. is chief of the Endocrinology Section at National Cancer Institute. Dr. Phang was a senior investigator in the Metabolism Branch, NCI. From 1989 to 1998, he served as chief of the Laboratory of Nutritional and Molecular Regulation, and in 1998, he formed the Metabolism and Cancer Susceptibility Section in the Basic Research Laboratory. The Section joined the Laboratory of Comparative Carcinogenesis in 2003. Dr. Phang received his M.D. from Loma Linda University School of Medicine and completed his training in internal medicine from Stanford Medical Center.